FDA approves Mylan generic HIV drug
PITTSBURGH — A generic antiretroviral drug for treating HIV infection has won approval from the Food and Drug Administration.
Mylan announced Wednesday the approval of nevirapine tablets in the 200-mg strength. The drug is a generic version of Boehringer Ingelheim's Viramune. Mylan plans to begin shipping the drug immediately.
Various versions of the drug had sales of $116.6 million during the 12-month period ended in March, according to IMS Health.